Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darren Cowzer

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of the National Cancer Institute|June 13, 2025
Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinomaFergus Keane, Lily V Saadat, Catherine A O'Connor, et al.
Annals of Surgery|February 10, 2023
Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma: A Phase Ib/II StudyDarren Cowzer, Abraham Jing-Ching Wu, Smita Sihag, et al.
Journal of the National Cancer Institute|September 27, 2024
Long-term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapyDarren Cowzer, Kevin Soares, Henry Walch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2026
Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract CancerDarren Cowzer, Henry Walch, Pranita Atri, et al.
JCO Precision Oncology|September 28, 2023
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular CarcinomaDarren Cowzer, Jessica B White, Joanne F Chou, et al.
The Oncologist|June 28, 2024
Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapyDarren Cowzer, Joanne F Chou, Henry Walch, et al.
JCO Precision Oncology|September 16, 2025
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract CancerDarren Cowzer, Madison Darmofal, Kenneth Seier, et al.
The Lancet. Oncology|September 4, 2023
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trialSamuel L Cytryn, Ryan H Moy, Darren Cowzer, et al.
Journal of the National Cancer Institute|October 26, 2024
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohortFergus Keane, Catherine O'Connor, Drew Moss, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 14, 2021
Early infection is an independent risk factor for increased mortality in patients with culture-confirmed infected pancreatic necrosisRobert A Moran, Christopher Halloran, Qiang Guo, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of the National Cancer Institute|June 13, 2025
Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinomaFergus Keane, Lily V Saadat, Catherine A O'Connor, et al.
Annals of Surgery|February 10, 2023
Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma: A Phase Ib/II StudyDarren Cowzer, Abraham Jing-Ching Wu, Smita Sihag, et al.
Journal of the National Cancer Institute|September 27, 2024
Long-term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapyDarren Cowzer, Kevin Soares, Henry Walch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2026
Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract CancerDarren Cowzer, Henry Walch, Pranita Atri, et al.
JCO Precision Oncology|September 28, 2023
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular CarcinomaDarren Cowzer, Jessica B White, Joanne F Chou, et al.
The Oncologist|June 28, 2024
Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapyDarren Cowzer, Joanne F Chou, Henry Walch, et al.
JCO Precision Oncology|September 16, 2025
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract CancerDarren Cowzer, Madison Darmofal, Kenneth Seier, et al.
The Lancet. Oncology|September 4, 2023
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trialSamuel L Cytryn, Ryan H Moy, Darren Cowzer, et al.
Journal of the National Cancer Institute|October 26, 2024
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohortFergus Keane, Catherine O'Connor, Drew Moss, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 14, 2021
Early infection is an independent risk factor for increased mortality in patients with culture-confirmed infected pancreatic necrosisRobert A Moran, Christopher Halloran, Qiang Guo, et al.
Pageof 3